Shares of GENinCode Plc (LON:GENI – Get Free Report) shot up 2.9% during trading on Thursday . The stock traded as high as GBX 4 ($0.05) and last traded at GBX 3.91 ($0.05). 54,995 shares traded hands during mid-day trading, a decline of 72% from the average session volume of 193,609 shares. The stock had previously closed at GBX 3.80 ($0.05).
GENinCode Trading Up 2.4 %
The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.27. The firm has a market cap of £6.88 million, a price-to-earnings ratio of -77.80 and a beta of 0.66. The company has a fifty day moving average price of GBX 4.05 and a 200-day moving average price of GBX 5.56.
GENinCode Company Profile
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Recommended Stories
- Five stocks we like better than GENinCode
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- The 3 Best Blue-Chip Stocks to Buy Now
- Top 3 ETFs to Hedge Against Inflation in 2025
- What Are Dividend Champions? How to Invest in the Champions
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
